Dx Deals: Quest Closes PathAI Partial Acquisition and Strategic Alliance
Deal is expected to give the lab giant a big boost in deploying artificial intelligence in the pathology space.
Keeps You Up-to-Date on Lab Business and Competitive Strategy, Market Trends and Opportunities, and M&A and Investment Activity in Today’s Diagnostic Lab Industry
Deal is expected to give the lab giant a big boost in deploying artificial intelligence in the pathology space.
From - Laboratory Industry Report
A new study in the New England Journal of Medicine has given credence to a molecular assay by California-based Genomic Health as a…
From - Laboratory Industry Report
While Theranos initially set out to change the laboratory sector with its Edison testing platform, to date it has mostly changed…
From - Laboratory Industry Report
Theranos continues to remake itself, shedding its longtime president and expanding its board of directors…